"Sly as a FOXO": New paths with forkhead signaling in the brain

Current Neurovascular Research

Volumn 4, Issue 4, 2007, Pages 295-302

  Maiese, Kenneth ^a   Zhao, Zhong Chong ^a   Yan, Chen Shang ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Akt; Amyotrophic lateral sclerosis; Apoptosis; Diabetes; Erythropoietin; FKHRL1; FOXO3a; Neuromuscular disease; Oxidative stress; Psychiatric; Stem cells; Stroke; Systemic lupus erythematosus

Indexed keywords

TRANSCRIPTION FACTOR FKHRL1;

BRAIN FUNCTION; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL ASSESSMENT; DEGENERATIVE DISEASE; DIABETES MELLITUS; HUMAN; INFLAMMATORY DISEASE; ISCHEMIA; LONGEVITY; NERVOUS SYSTEM; NEUROMUSCULAR DISEASE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RISK ASSESSMENT; SENESCENCE;

ANIMALS; BRAIN; FORKHEAD TRANSCRIPTION FACTORS; GENE DELETION; HUMANS; MICE; MICE, KNOCKOUT; NERVOUS SYSTEM DISEASES; SIGNAL TRANSDUCTION;

EID: 36448967502     PISSN: 15672026     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720207782446306     Document Type: Review

References (129)

1. Abid, MR, Guo, S, Minami, T, Spokes, KC, Ueki, K, Skurk, C, Walsh, K, Aird, WC. (2004) Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells. Arterioscler Thromb Vasc Biol 24: 294-300.
2. Anderson, MJ, Viars, CS, Czekay, S, Cavenee, WK, Arden, KC. (1998) Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily. Genomics 47: 187-99.
3. Anitha, M, Gondha, C, Sutliff, R, Parsadanian, A, Mwangi, S, Sitaraman, SV, Srinivasan, S. (2006) GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway. J Clin Invest 116: 344-56.
4. Awad, N, Gagnon, M, Messier, C. (2004) The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol 26: 1044-80.
5. Barthelemy, C, Henderson, CE, Pettmann, B. (2004) Foxo3a induces motoneuron death through the Fas pathway in cooperation with JNK. BMC Neurosci 5: 48.
6. Belguise, K, Guo, S, Sonenshein, GE. (2007) Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor {alpha} expression reversing invasive phenotype of breast cancer cells. Cancer Res 67: 5763-70.
7. Bitterman, KJ, Anderson, RM, Cohen, HY, Latorre-Esteves, M, Sinclair, DA. (2002) Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J Biol Chem 277: 45099-107.
8. Brunet, A, Bonni, A, Zigmond, MJ, Lin, MZ, Juo, P, Hu, LS, Anderson, MJ, Arden, KC, Blenis, J, Greenberg, ME. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-68.
9. Brunet, A, Kanai, F, Stehn, J, Xu, J, Sarbassova, D, Frangioni, JV, Dalal, SN, DeCaprio, JA, Greenberg, ME, Yaffe, MB. (2002) 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. J Cell Biol 156: 817-28.
10. Brunet, A, Park, J, Tran, H, Hu, LS, Hemmings, BA, Greenberg, ME. (2001) Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol 21: 952-65.
11. Brunet, A, Sweeney, LB, Sturgill, JF, Chua, KF, Greer, PL, Lin, Y, Tran, H, Ross, SE, Mostoslavsky, R, Cohen, HY, Hu, LS, Cheng, HL, Jedrychowski, MP, Gygi, SP, Sinclair, DA, Alt, FW, Greenberg, ME. (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303: 2011-5.
12. Cahill, CM, Tzivion, G, Nasrin, N, Ogg, S, Dore, J, Ruvkun, G, Alexander-Bridges, M. (2001) Phosphatidylinositol 3-kinase signaling inhibits DAF-16 DNA binding and function via 14-3-3-dependent and 14-3-3-independent pathways. J Biol Chem 276: 13402-10.
13. Castrillon, DH, Miao, L, Kollipara, R, Horner, JW, DePinho, RA. (2003) Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science 301: 215-8.
14. Charvet, C, Alberti, I, Luciano, F, Jacquel, A, Bernard, A, Auberger, P, Deckert, M. (2003) Proteolytic regulation of Forkhead transcription factor FOXO3a by caspase-3-like proteases. Oncogene 22: 4557-68.
15. Chong, ZZ, Kang, J, Li, F, Maiese, K. (2005a) mGluRI targets microglial activation and selectively prevents neuronal cell engulfment through Akt and caspase dependent pathways. Curr Neurovasc Res 2: 197-211.
16. Chong, ZZ, Kang, JQ, Maiese, K. (2004a) Akt1 drives endothelial cell membrane asymmetry and microglial activation through Bcl-x(L) and caspase 1, 3, and 9. Exp Cell Res 296: 196-207.
17. Chong, ZZ, Kang, JQ, Maiese, K. (2003a) Apaf-1, Bcl-xL, cytochrome c, and caspase-9 form the critical elements for cerebral vascular protection by erythropoietin. J Cereb Blood Flow Metab 23: 320-30.
18. Chong, ZZ, Kang, JQ, Maiese, K. (2003b) Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways. Br J Pharmacol 138: 1107-1118.
19. Chong, ZZ, Kang, JQ, Maiese, K. (2002a) Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation 106: 2973-9.
20. Chong, ZZ, Kang, JQ, Maiese, K. (2004b) Essential cellular regulatory elements of oxidative stress in early and late phases of apoptosis in the central nervous system. Antioxid Redox Signal 6: 277-87.
21. Chong, ZZ, Li, F, Maiese, K. (2005b) Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury. Histol Histopathol 20: 299-315.
22. Chong, ZZ, Li, F, Maiese, K. (2007a) Cellular demise and inflammatory microglial activation during beta-amyloid toxicity are governed by Wnt1 and canonical signaling pathways. Cell Signal 19: 1150-62.
23. Chong, ZZ, Li, F, Maiese, K. (2005c) Employing new cellular therapeutic targets for Alzheimer's disease: a change for the better? Curr Neurovasc Res 2: 55-72.
24. Chong, ZZ, Li, F, Maiese, K. (2005d) Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity. Curr Neurovasc Res 2: 387-99.
25. Chong, ZZ, Li, F, Maiese, K. (2006) Group I metabotropic receptor neuroprotection requires Akt and its substrates that govern FOXO3a, Bim, and beta-catenin during oxidative stress. Curr Neurovasc Res 3: 107-17.
26. Chong, ZZ, Li, F, Maiese, K. (2005e) Oxidative stress in the brain: Novel cellular targets that govern survival during neurodegenerative disease. Prog Neurobiol 75: 207-46.
27. Chong, ZZ, Li, F, Maiese, K. (2005f) Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease. Brain Res Brain Res Rev 49: 1-21.
28. Chong, ZZ, Li, F, Maiese, K. (2007b) The pro-survival pathways of mTOR and protein kinase B target glycogen synthase kinase-3beta and nuclear factor-kappaB to foster endogenous microglial cell protection. Int J Mol Med 19: 263-72.
29. Chong, ZZ, Lin, SH, Kang, JQ, Maiese, K. (2003c) Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8. J Neurosci Res 71: 659-69.
30. Chong, ZZ, Lin, SH, Li, F, Maiese, K. (2005g) The sirtuin inhibitor nicotinamide enhances neuronal cell survival during acute anoxic injury through Akt, Bad, PARP, and mitochondrial associated "anti-apoptotic" pathways. Curr Neurovasc Res 2: 271-85.
31. Chong, ZZ, Lin, SH, Maiese, K. (2002b) Nicotinamide Modulates Mitochondrial Membrane Potential and Cysteine Protease Activity during Cerebral Vascular Endothelial Cell Injury. J Vasc Res 39: 131-47.
32. Chong, ZZ, Lin, SH, Maiese, K. (2004c) The NAD+ precursor nicotinamide governs neuronal survival during oxidative stress through protein kinase B coupled to FOXO3a and mitochondrial membrane potential. J Cereb Blood Flow Metab 24: 728-43.
33. Chong, ZZ, Maiese, K. (2007a) Erythropoietin involves the phosphatidylinositol 3-kinase pathway, 14-3-3 protein and FOXO3a nuclear trafficking to preserve endothelial cell integrity. Br J Pharmacol 150: 839-50.
34. Chong, ZZ, Maiese, K. (2007b) The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury. Histol Histopathol 22: 1251-67.
35. Chong, ZZ, Shang, YC, Maiese, K. (2007c) Vascular injury during elevated glucose can be mitigated by erythropoietin and Wnt signaling. Curr Neurovasc Res 4: 194-204.
36. Clark, KL, Halay, ED, Lai, E, Burley, SK. (1993) Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature 364: 412-20.
37. Crino, A, Schiaffini, R, Ciampalini, P, Suraci, MC, Manfrini, S, Visalli, N, Matteoli, MC, Patera, P, Buzzetti, R, Guglielmi, C, Spera, S, Costanza, F, Fioriti, E, Pitocco, D, Pozzilli, P. (2005) A two year observational study of nicotinamide and intensive insulin therapy in patients with recent onset type 1 diabetes mellitus. J Pediatr Endocrinol Metab 18: 749-54.
38. Delpuech, O, Griffiths, B, East, P, Essafi, A, Lam, EW, Burgering, B, Downward, J, Schulze, A. (2007) Induction of Mxi1-SR{alpha} by FOXO3a contributes to repression of Myc-dependent gene expression. Mol Cell Biol 27: 4917-30.
39. Dong, S, Kang, S, Gu, TL, Kardar, S, Fu, H, Lonial, S, Khoury, HJ, Khuri, F, Chen, J. (2007) 14-3-3 integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells. Blood 110: 360-9.
40. Eto, N, Miyata, Y, Ohno, H, Yamashita, T. (2005) Nicotinamide prevents the development of hyperphosphataemia by suppressing intestinal sodium-dependent phosphate transporter in rats with adenine-induced renal failure. Nephrol Dial Transplant 20: 1378-84.
41. Fallarino, F, Bianchi, R, Orabona, C, Vacca, C, Belladonna, ML, Fioretti, MC, Serreze, DV, Grohmann, U, Puccetti, P. (2004) CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice. J Exp Med 200: 1051-62.
42. Finnberg, N, El-Deiry, WS. (2004) Activating FOXO3a, NF-kappaB and p53 by targeting IKKs: an effective multi-faceted targeting of the tumor-cell phenotype? Cancer Biol Ther 3: 614-6.
43. Frye, RA. (2000) Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys Res Commun 273: 793-8.
44. Furukawa-Hibi, Y, Yoshida-Araki, K, Ohta, T, Ikeda, K, Motoyama, N. (2002) FOXO forkhead transcription factors induce G(2)-M checkpoint in response to oxidative stress. J Biol Chem 277: 26729-32.
45. Furuyama, T, Nakazawa, T, Nakano, I, Mori, N. (2000) Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem J 349: 629-34.
46. Gerozissis, K. (2003) Brain insulin: regulation, mechanisms of action and functions. Cell Mol Neurobiol 23: 1-25.
47. Hageman, GJ, Stierum, RH. (2001) Niacin, poly(ADP-ribose) polymerase-1 and genomic stability. Mutat Res 475: 45-56.
48. Han, HS, Suk, K. (2005) The function and integrity of the neurovascular unit rests upon the integration of the vascular and inflammatory cell systems. Curr Neurovasc Res 2: 409-23.
49. Henry, MK, Lynch, JT, Eapen, AK, Quelle, FW. (2001) DNA damage-induced cell-cycle arrest of hematopoietic cells is overridden by activation of the PI-3 kinase/Akt signaling pathway. Blood 98: 834-41.
50. Hoekman, MF, Jacobs, FM, Smidt, MP, Burbach, JP. (2006) Spatial and temporal expression of FoxO transcription factors in the developing and adult murine brain. Gene Expr Patterns 6: 134-40.
51. Hong, JR, Lin, GH, Lin, CJ, Wang, WP, Lee, CC, Lin, TL, Wu, JL. (2004) Phosphatidylserine receptor is required for the engulfment of dead apoptotic cells and for normal embryonic development in zebrafish. Development 131: 5417-27.
52. Hosaka, T, Biggs, WH, 3rd, Tieu, D, Boyer, AD, Varki, NM, Cavenee, WK, Arden, KC. (2004) Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc Natl Acad Sci U S A 101: 2975-80.
53. Hu, MC, Lee, DF, Xia, W, Golfman, LS, Ou-Yang, F, Yang, JY, Zou, Y, Bao, S, Hanada, N, Saso, H, Kobayashi, R, Hung, MC. (2004) IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117: 225-37.
54. Hu, Y, Wang, Y, Wang, L, Zhang, H, Zhao, B, Zhang, A, Li, Y. (1996) Effects of nicotinamide on prevention and treatment of streptozotocininduced diabetes mellitus in rats. Chin Med J (Engl) 109: 819-22.
55. Hur, EM, Youssef, S, Haws, ME, Zhang, SY, Sobel, RA, Steinman, L. (2007) Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat Immunol 8: 74-83.
56. Jackson, TM, Rawling, JM, Roebuck, BD, Kirkland, JB. (1995) Large supplements of nicotinic acid and nicotinamide increase tissue NAD+ and poly(ADP-ribose) levels but do not affect diethylnitrosamine-induced altered hepatic foci in Fischer-344 rats. J Nutr 125: 1455-61.
57. Jin, C, Marsden, I, Chen, X, Liao, X. (1998) Sequence specific collective motions in a winged helix DNA binding domain detected by 15N relaxation NMR. Biochemistry 37: 6179-87.
58. Jonsson, H, Allen, P, Peng, SL. (2005) Inflammatory arthritis requires Foxo3a to prevent Fas ligand-induced neutrophil apoptosis. Nat Med 11: 666-71.
59. Kaestner, KH, Knochel, W, Martinez, DE. (2000) Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev 14: 142-6.
60. Kamei, Y, Miura, S, Suzuki, M, Kai, Y, Mizukami, J, Taniguchi, T, Mochida, K, Hata, T, Matsuda, J, Aburatani, H, Nishino, I, Ezaki, O. (2004) Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J Biol Chem 279: 41114-23.
61. Kang, JQ, Chong, ZZ, Maiese, K. (2003a) Akt1 protects against inflammatory microglial activation through maintenance of membrane asymmetry and modulation of cysteine protease activity. J Neurosci Res 74: 37-51.
62. Kang, JQ, Chong, ZZ, Maiese, K. (2003b) Critical role for Akt1 in the modulation of apoptotic phosphatidylserine exposure and microglial activation. Mol Pharmacol 64: 557-69.
63. Kato, M, Yuan, H, Xu, ZG, Lanting, L, Li, SL, Wang, M, Hu, MC, Reddy, MA, Natarajan, R. (2006) Role of the Akt/FoxO3a pathway in TGFbeta1-mediated mesangial cell dysfunction: a novel mechanism related to diabetic kidney disease. J Am Soc Nephrol 17: 3325-35.
64. Kim, JR, Jung, HS, Bae, SW, Kim, JH, Park, BL, Choi, YH, Cho, HY, Cheong, HS, Shin, HD. (2006) Polymorphisms in FOXO gene family and association analysis with BMI. Obesity (Silver Spring, Md) 14: 188-93.
65. Kino, T, De Martino, MU, Charmandari, E, Ichijo, T, Outas, T, Chrousos, GP. (2005) HIV-1 accessory protein Vpr inhibits the effect of insulin on the Foxo subfamily of forkhead transcription factors by interfering with their binding to 14-3-3 proteins: potential clinical implications regarding the insulin resistance of HIV-1-infected patients. Diabetes 54: 23-31.
66. Kitamura, YI, Kitamura, T, Kruse, JP, Raum, JC, Stein, R, Gu, W, Accili, D. (2005) FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell Metab 2: 153-63.
67. Kuningas, M, Magi, R, Westendorp, RG, Slagboom, PE, Remm, M, van Heemst, D. (2007) Haplotypes in the human Foxo1a and Foxo3a genes; impact on disease and mortality at old age. Eur J Hum Genet 15: 294-301.
68. Kyoung Kim, H, Kyoung Kim, Y, Song, IH, Baek, SH, Lee, SR, Hye Kim, J, Kim, JR. (2005) Down-regulation of a forkhead transcription factor, FOXO3a, accelerates cellular senescence in human dermal fibroblasts. J Gerontol A Biol Sci Med Sci 60: 4-9.
69. Laakso, M. (2001) Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention. J Intern Med 249: 225-35.
70. Larson, ET, Eilers, B, Menon, S, Reiter, D, Ortmann, A, Young, MJ, Lawrence, CM. (2007) A winged-helix protein from sulfolobus turreted icosahedral virus points toward stabilizing disulfide bonds in the intracellular proteins of a hyperthermophilic virus. Virology [Epub ahead of print].
71. Leger, B, Vergani, L, Soraru, G, Hespel, P, Derave, W, Gobelet, C, D'Ascenzio, C, Angelini, C, Russell, AP. (2006) Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. FASEB J 20: 583-5.
72. Lehtinen, MK, Yuan, Z, Boag, PR, Yang, Y, Villen, J, Becker, EB, DiBacco, S, de la Iglesia, N, Gygi, S, Blackwell, TK, Bonni, A. (2006) A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell 125: 987-1001.
73. Leong, ML, Maiyar, AC, Kim, B, O'Keeffe, BA, Firestone, GL. (2003) Expression of the serum- and glucocorticoid-inducible protein kinase, Sgk, is a cell survival response to multiple types of environmental stress stimuli in mammary epithelial cells. J Biol Chem 278: 5871-82.
74. Li, F, Chong, ZZ, Maiese, K. (2006a) Cell life versus cell longevity: the mysteries surrounding the NAD(+) precursor nicotinamide. Curr Med Chem 13: 883-95.
75. Li, F, Chong, ZZ, Maiese, K. (2004a) Erythropoietin on a tightrope: balancing neuronal and vascular protection between intrinsic and extrinsic pathways. Neurosignals 13: 265-89.
76. Li, F, Chong, ZZ, Maiese, K. (2006b) Microglial integrity is maintained by erythropoietin through integration of Akt and its substrates of glycogen synthase kinase-3beta, beta-catenin, and nuclear factor-kappaB. Curr Neurovasc Res 3: 187-201.
77. Li, F, Chong, ZZ, Maiese, K. (2004b) Navigating novel mechanisms of cellular plasticity with the NAD+ precursor and nutrient nicotinamide. Front Biosci 9: 2500-2520.
78. Li, M, Chiu, JF, Mossman, BT, Fukagawa, NK. (2006c) Down-regulation of manganese-superoxide dismutase through phosphorylation of FOXO3a by Akt in explanted vascular smooth muscle cells from old rats. J Biol Chem 281: 40429-39.
79. Lin, L, Hron, JD, Peng, SL. (2004) Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 21: 203-13.
80. Lin, SH, Chong, ZZ, Maiese, K. (2001) Nicotinamide: A nutritional supplement that provides protection against neuronal and vascular injury. J Med Food 4: 27-38.
81. Lin, SH, Maiese, K. (2001) The metabotropic glutamate receptor system protects against ischemic free radical programmed cell death in rat brain endothelial cells. J Cereb Blood Flow Metab 21: 262-75.
82. Lin, SH, Vincent, A, Shaw, T, Maynard, KI, Maiese, K. (2000) Prevention of nitric oxide-induced neuronal injury through the modulation of independent pathways of programmed cell death. J Cereb Blood Flow Metab 20: 1380-91.
83. Magni, G, Amici, A, Emanuelli, M, Orsomando, G, Raffaelli, N, Ruggieri, S. (2004) Enzymology of NAD+ homeostasis in man. Cell Mol Life Sci 61: 19-34.
84. Mahmud, DL, G-Amlak, M, Deb, DK, Platanias, LC, Uddin, S, Wickrema, A. (2002) Phosphorylation of forkhead transcription factors by erythropoietin and stem cell factor prevents acetylation and their interaction with coactivator p300 in erythroid progenitor cells. Oncogene 21: 1556-62.
85. Maiese, K, Chong, ZZ. (2004) Insights into oxidative stress and potential novel therapeutic targets for Alzheimer disease. Restor Neurol Neurosci 22: 87-104.
86. Maiese, K, Chong, ZZ. (2003) Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain. Trends Pharmacol Sci 24: 228-32.
87. Maiese, K, Chong, ZZ, Li, F. (2005a) Driving cellular plasticity and survival through the signal transduction pathways of metabotropic glutamate receptors. Curr Neurovasc Res 2: 425-46.
88. Maiese, K, Chong, ZZ, Shang, YC. (2007) Mechanisitic insights into diabetes mellitus and oxidative stress. Curr Med Chem 14: 1689-1699.
89. Maiese, K, Li, F, Chong, ZZ. (2004) Erythropoietin in the brain: can the promise to protect be fulfilled? Trends Pharmacol Sci 25: 577-583.
90. Maiese, K, Li, F, Chong, ZZ. (2005b) New avenues of exploration for erythropoietin. JAMA 293: 90-5.
91. Martin, D, Salinas, M, Lopez-Valdaliso, R, Serrano, E, Recuero, M, Cuadrado, A. (2001) Effect of the Alzheimer amyloid fragment Abeta(25-35) on Akt/PKB kinase and survival of PC12 cells. J Neurochem 78: 1000-8.
92. Matsuzaki, H, Tamatani, M, Mitsuda, N, Namikawa, K, Kiyama, H, Miyake, S, Tohyama, M. (1999) Activation of Akt kinase inhibits apoptosis and changes in Bcl-2 and Bax expression induced by nitric oxide in primary hippocampal neurons. J Neurochem 73: 2037-46.
93. Miyamoto, K, Araki, KY, Naka, K, Arai, F, Takubo, K, Yamazaki, S, Matsuoka, S, Miyamoto, T, Ito, K, Ohmura, M, Chen, C, Hosokawa, K, Nakauchi, H, Nakayama, K, Nakayama, KI, Harada, M, Motoyama, N, Suda, T, Hirao, A. (2007) Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell 1: 101-112.
94. Miyauchi, H, Minamino, T, Tateno, K, Kunieda, T, Toko, H, Komuro, I. (2004) Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway. EMBO J 23: 212-20.
95. Motta, MC, Divecha, N, Lemieux, M, Kamel, C, Chen, D, Gu, W, Bultsma, Y, McBurney, M, Guarente, L. (2004) Mammalian SIRT1 represses forkhead transcription factors. Cell 116: 551-63.
96. Munoz-Fontela, C, Marcos-Villar, L, Gallego, P, Arroyo, J, Da Costa, M, Pomeranz, KM, Lam, EW, Rivas, C. (2007) Latent protein LANA2 from Kaposi's sarcoma-associated herpesvirus interacts with 14-3-3 proteins and inhibits FOXO3a transcription factor. J Virol 81: 1511-6.
97. Namikawa, K, Honma, M, Abe, K, Takeda, M, Mansur, K, Obata, T, Miwa, A, Okado, H, Kiyama, H. (2000) Akt/protein kinase B prevents injury-induced motoneuron death and accelerates axonal regeneration. J Neurosci 20: 2875-86.
98. Nemoto, S, Fergusson, MM, Finkel, T. (2004) Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science 306: 2105-8.
99. Obexer, P, Geiger, K, Ambros, PF, Meister, B, Ausserlechner, MJ. (2007) FKHRL1-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells. Cell Death Differ 14: 534-47.
100. Olmos, PR, Hodgson, MI, Maiz, A, Manrique, M, De Valdes, MD, Foncea, R, Acosta, AM, Emmerich, MV, Velasco, S, Muniz, OP, Oyarzun, CA, Claro, JC, Bastias, MJ, Tora, LA. (2005) Nicotinamide protected first-phase insulin response (FPIR) and prevented clinical disease in first-degree relatives of type-1 diabetics. Diabetes Res Clin Pract 71: 320-33.
101. Perkins, BA, Bril, V. (2002) Diagnosis and management of diabetic neuropathy. Curr Diab Rep 2: 495-500.
102. Pirianov, G, Brywe, KG, Mallard, C, Edwards, AD, Flavell, RA, Hagberg, H, Mehmet, H. (2007) Deletion of the c-Jun N-terminal kinase 3 gene protects neonatal mice against cerebral hypoxic-ischaemic injury. J Cereb Blood Flow Metab 27: 1022-32.
103. Porcu, M, Chiarugi, A. (2005) The emerging therapeutic potential of sirtuin-interacting drugs: from cell death to lifespan extension. Trends Pharmacol Sci 26: 94-103.
104. Quinn, L. (2001) Type 2 diabetes: epidemiology, pathophysiology, and diagnosis. Nurs Clin North Am 36: 175-92, v.
105. Ramnanan, CJ, Groom, AG, Storey, KB. (2007) Akt and its downstream targets play key roles in mediating dormancy in land snails. Comp Biochem Physiol B Biochem Mol Biol [Epub ahead of print].
106. Real, PJ, Benito, A, Cuevas, J, Berciano, MT, de Juan, A, Coffer, P, Gomez-Roman, J, Lafarga, M, Lopez-Vega, JM, Fernandez-Luna, JL. (2005) Blockade of epidermal growth factor receptors chemosensitizes breast cancer cells through up-regulation of Bnip3L. Cancer Res 65: 8151-7.
107. Reddy, S, Bibby, NJ, Wu, D, Swinney, C, Barrow, G, Elliott, RB. (1995) A combined casein-free-nicotinamide diet prevents diabetes in the NOD mouse with minimum insulitis. Diabetes Res Clin Pract 29: 83-92.
108. Relling, DP, Esberg, LB, Fang, CX, Johnson, WT, Murphy, EJ, Carlson, EC, Saari, JT, Ren, J. (2006) High-fat diet-induced juvenile obesity leads to cardiomyocyte dysfunction and upregulation of Foxo3a transcription factor independent of lipotoxicity and apoptosis. J Hypertens 24: 549-61.
109. Rice, L, Handayani, R, Cui, Y, Medrano, T, Samedi, V, Baker, H, Szabo, NJ, Rosser, CJ, Goodison, S, Shiverick, KT. (2007) Soy isoflavones exert differential effects on androgen responsive genes in LNCaP human prostate cancer cells. J Nutr 137: 964-72.
110. Rytomaa, M, Lehmann, K, Downward, J. (2000) Matrix detachment induces caspase-dependent cytochrome c release from mitochondria: inhibition by PKB/Akt but not Raf signalling. Oncogene 19: 4461-8.
111. Sadanaga-Akiyoshi, F, Yao, H, Tanuma, S, Nakahara, T, Hong, JS, Ibayashi, S, Uchimura, H, Fujishima, M. (2003) Nicotinamide attenuates focal ischemic brain injury in rats: with special reference to changes in nicotinamide and NAD+ levels in ischemic core and penumbra. Neurochem Res 28: 1227-34.
112. Sandri, M, Sandri, C, Gilbert, A, Skurk, C, Calabria, E, Picard, A, Walsh, K, Schiaffino, S, Lecker, SH, Goldberg, AL. (2004) Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117: 399-412.
113. Sela, U, Dayan, M, Hershkoviz, R, Cahalon, L, Lider, O, Mozes, E. (2006) The negative regulators Foxj1 and Foxo3a are up-regulated by a peptide that inhibits systemic lupus erythematosus-associated T cell responses. Eur J Immunol 36: 2971-80.
114. Tanaka, M, Kirito, K, Kashii, Y, Uchida, M, Watanabe, T, Endo, H, Endoh, T, Sawada, K, Ozawa, K, Komatsu, N. (2001) Forkhead family transcription factor FKHRL1 is expressed in human megakaryocytes. Regulation of cell cycling as a downstream molecule of thrombopoietin signaling. J Biol Chem 276: 15082-9.
115. Tothova, Z, Kollipara, R, Huntly, BJ, Lee, BH, Castrillon, DH, Cullen, DE, McDowell, EP, Lazo-Kallanian, S, Williams, IR, Sears, C, Armstrong, SA, Passegue, E, DePinho, RA, Gilliland, DG. (2007) FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128: 325-39.
116. Tran, H, Brunet, A, Grenier, JM, Datta, SR, Fornace, AJ, Jr., DiStefano, PS, Chiang, LW, Greenberg, ME. (2002) DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein. Science 296: 530-4.
117. Van Der Heide, LP, Hoekman, MF, Smidt, MP. (2004) The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem J 380: 297-309.
118. Vaziri, H, Dessain, SK, Ng Eaton, E, Imai, SI, Frye, RA, Pandita, TK, Guarente, L, Weinberg, RA. (2001) hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107: 149-59.
119. Wang, F, Nguyen, M, Qin, FX, Tong, Q. (2007) SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction. Aging Cell 6: 505-14.
120. Wick, A, Wick, W, Waltenberger, J, Weller, M, Dichgans, J, Schulz, JB. (2002) Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J Neurosci 22: 6401-7.
121. Wijchers, PJ, Burbach, JP, Smidt, MP. (2006) In control of biology: of mice, men and Foxes. Biochem J 397: 233-46.
122. Wild, S, Roglic, G, Green, A, Sicree, R, King, H. (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-53.
123. Won, CK, Ji, HH, Koh, PO. (2006) Estradiol prevents the focal cerebral ischemic injury-induced decrease of forkhead transcription factors phosphorylation. Neurosci Lett 398: 39-43.
124. Yamaguchi, H, Wang, HG. (2001) The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene 20: 7779-86.
125. You, H, Jang, Y, You-Ten, AI, Okada, H, Liepa, J, Wakeham, A, Zaugg, K, Mak, TW. (2004) p53-dependent inhibition of FKHRL1 in response to DNA damage through protein kinase SGK1. Proc Natl Acad Sci U S A 101: 14057-62.
126. Zheng, WH, Kar, S, Quirion, R. (2002) FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling. J Neurochem 80: 1049-61.
127. Zheng, WH, Kar, S, Quirion, R. (2000) Insulin-like growth factor-1-induced phosphorylation of the forkhead family transcription factor FKHRL1 is mediated by Akt kinase in PC12 cells. J Biol Chem 275: 39152-8.
128. Zhou, ZQ, Wang, T, Pan, LM, Huang, RH, Shi, FX. (2007) FoxO4 is the main forkhead transcriptional factor localized in the gastrointestinal tracts of pigs. J Zhejiang Univ Sci 8: 39-44.
129. Zhu, W, Bijur, GN, Styles, NA, Li, X. (2004) Regulation of FOXO3a by brain-derived neurotrophic factor in differentiated human SH-SY5Y neuroblastoma cells. Brain Res Mol Brain Res 126: 45-56.